Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 28, 2020; 26(44): 7076-7084
Published online Nov 28, 2020. doi: 10.3748/wjg.v26.i44.7076
Published online Nov 28, 2020. doi: 10.3748/wjg.v26.i44.7076
Table 1 Laboratory tests of patients
No symptoms | Start symptoms | Start treatment | After treatment | |
Laboratory parameters | February 22 | March 10 | March 16 | March 24 |
AST, UI/L | 24 | 22 | 32 | 26 |
ALT, UI/L | 19 | 28 | 16 | 24 |
Total bilirubin (µmol/L) | 6.5 | 3.5 | 8 | 8 |
Albumin (g/L) | 33 | 35 | 33 | 31 |
Creatinine (µmol/L) | 118.6 | 119 | 135 | 134.5 |
Hemoglobin (g/L) | 12.1 | 12.5 | 12.5 | 11.7 |
Platelet | 159000 | 122000 | 136000 | 296000 |
Lymphocytes | 1020 | 1050 | 390 | 996 |
PT (%) | 100 | 86 | 27 | 88 |
INR | 1 | 1.05 | 1.5 | 1.1 |
Tacrolimus (ng/mL) | 3.5 | 3.5 | 3.2 | 3.8 |
CRP (mg/L) | 3.05 | 12.4 | 112.28 | 6.6 |
- Citation: Sessa A, Mazzola A, Lim C, Atif M, Pappatella J, Pourcher V, Scatton O, Conti F. COVID-19 in a liver transplant recipient: Could iatrogenic immunosuppression have prevented severe pneumonia? A case report. World J Gastroenterol 2020; 26(44): 7076-7084
- URL: https://www.wjgnet.com/1007-9327/full/v26/i44/7076.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i44.7076